← Back to Search

Procedure

Latarjet Procedure vs Anatomic Glenoid Reconstruction for Shoulder Dislocation

N/A
Recruiting
Led By Ivan Wong, MD
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 and 2 years
Awards & highlights

Study Summary

This trial compares two surgical treatments for shoulder dislocations to reduce pain, increase function & lower risk of recurrence.

Who is the study for?
This trial is for individuals who have experienced one or more anterior shoulder dislocations and show over 20% bone loss on a pre-operative CT scan. It's not suitable for those with posterior or multidirectional instability, massive rotator cuff tears, substance abuse history, or inability to consent or accept random treatment assignment.Check my eligibility
What is being tested?
The study compares two surgical methods for treating recurrent shoulder dislocation due to bone loss: Latarjet procedure (coracoid transfer) versus Anatomic Glenoid Reconstruction using distal tibia allograft with Bankart repair. The goal is to assess which surgery offers better clinical and radiographic outcomes post-operation.See study design
What are the potential side effects?
Potential side effects of the surgeries may include pain, stiffness in the shoulder joint, infection risk at the surgical site, nerve damage around the operated area, and complications related to grafting such as graft failure or arthritis development.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 and 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Complication reporting
Secondary outcome measures
American Shoulder and Elbow Surgeon (ASES) Assessment Form
EQ5D-5L
Radiographic measure - glenoid size
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Anatomic Glenoid ReconstructionExperimental Treatment1 Intervention
An allograft will be used for the patients in this group, inserted through a new portal and fixed to the anterior rim of the glenoid to recreate the size of the glenoid.
Group II: LatarjetActive Control1 Intervention
The Latarjet involves the use of a auto-graft to be fixated to the anterior portion of the glenoid to recreate the size of the glenoid.

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
258 Previous Clinical Trials
83,786 Total Patients Enrolled
2 Trials studying Shoulder Dislocation
220 Patients Enrolled for Shoulder Dislocation
Ivan Wong, MDPrincipal InvestigatorNova Scotia Health Authority, Orthopaedic Surgeon
4 Previous Clinical Trials
142 Total Patients Enrolled

Media Library

Anatomic Glenoid Reconstruction (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05658289 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study recruiting participants at the present time?

"Data posted on clinicaltrials.gov asserts that enrollment for this medical trial is open, beginning from April 24th 2023 and most recently updated on the same day."

Answered by AI

Am I eligible to join this clinical trial?

"This clinical trial is recruiting 68 participants between 16 and 40 years old who have had shoulder arthroscopy. The essential criteria that applicants must meet include having a history of anterior shoulder dislocation, as well as displaying 20% or more bone loss on pre-operative CT scans."

Answered by AI

Is this study open to those over the age of 18?

"This research initiative is seeking participants that are between the ages of 16 and 40. For those younger or older than this demographic, there are 13 studies for minors and 32 studies targeting individuals over 65 years old."

Answered by AI

What is the participant capacity for this research project?

"Confirmed, according to clinicaltrials.gov this research project is currently recruiting patients and has been since April 24th 2023. 68 participants will be needed from 1 location for the duration of the trial."

Answered by AI
~34 spots leftby Apr 2025